The novartis health index: A method for valuing the economic impact of risk reduction in a workforce

Journal of Occupational and Environmental Medicine

Volumn 52, Issue 5, 2010, Pages 528-535

  Kelly, Emily ^a   Carls, Ginger S ^a   Lenhart, Greg ^a   Mauceri, Edward ^b   Columbus, Daniel ^b   Cavuoti, Ann ^c   Goetzel, Ron Z ^a  

^a THOMSON REUTERS   (United Kingdom)

^b NOVARTIS PHARMA AG   (Switzerland)

^c EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALCOHOL CONSUMPTION; ANALYTIC METHOD; ARTICLE; CALCULATOR; CONTROLLED STUDY; COST CONTROL; ECONOMIC EVALUATION; EMOTIONAL STABILITY; EMPLOYEE; FEMALE; HUMAN; MALE; NOVARTIS HEALTH INDEX; OCCUPATIONAL HAZARD; OCCUPATIONAL HEALTH; RISK MANAGEMENT; RISK REDUCTION; SMOKING;

NICOTIANA TABACUM;

EID: 77952302210     PISSN: 10762752     EISSN: None     Source Type: Journal    
DOI: 10.1097/JOM.0b013e3181dbe339     Document Type: Article

References (26)

1. Goetzel RZ, Anderson DR, Whitmer RW, Ozminkowski RJ, Dunn RL, Wasserman J; Health Enhancement Research Organization (HERO) Research Committee. The relationship between modifiable health risks and health care expenditures. An analysis of the multi-employer HERO health risk and cost database. J Occup Environ Med. 1998;40:843-854.
2. Anderson DR, Whitmer RW, Goetzel RZ, et al; Health Enhancement Research Organization (HERO) Research Committee. The relationship between modifiable health risks and group-level health care expenditures. Health Enhancement Research Organization (HERO) Research Committee. Am J Health Promot. 2000;15:45-52.
3. Pronk NP, Goodman MJ, O'Connor PJ, Martinson BC. Relationship between modifiable health risks and short-term health care charges. JAMA. 1999;282:2235-2239.
4. Yen L, McDonald T, Hirschland D, Edington DW. Association between wellness score from a health risk appraisal and prospective medical claims costs. J Occup Environ Med. 2003;45:1049-1057.
5. Burton WN, Chen CY, Conti DJ, Schultz AB, Edington DW. Measuring the relationship between employees' health risk factors and corporate pharmaceutical expenditures. J Occup Environ Med. 2003;45:793-802.
6. Dall TM, Zhang Y, Chen YJ, et al. Cost associated with being overweight and with obesity, high alcohol consumption, and tobacco use within the military health system's TRICARE prime-enrolled population. Am J Health Promot. 2007;22:120-139.
7. Durden ED, Huse D, Ben-Joseph R, Chu BC. Economic costs of obesity to self-insured employers. J Occup Environ Med. 2008;50:991-997.
8. Goetzel RZ, Carls GS, Wang S, et al. The relationship between modifiable health risk factors and medical expenditures, absenteeism, short-term disability, and presenteeism among employees at Novartis. J Occup Environ Med. 2009;51:487-499.
9. Boles M, Pelletier B, Lynch W. The relationship between health risks and work productivity. J Occup Environ Med. 2004;46:737-745. (Pubitemid 38938250)
10. Burton WN, Chen CY, Conti DJ, Schultz AB, Pransky G, Edington DW. The association of health risks with on-the-job productivity. J Occup Environ Med. 2005;47:769-777.
11. Serxner SA, Gold DB, Bultman KK. The impact of behavioral health risks on worker absenteeism. J Occup Environ Med. 2001;43:347-354.
12. Burton WN, Pransky G, Conti DJ, Chen CY, Edington DW. The association of medical conditions and presenteeism. J Occup Environ Med. 2004; 46: S38-S45.
13. Riedel JE, Grossmeier J, Haglund-Howieson L, Buraglio C, Anderson DV, Terry PE. Use of a normal impairment factor in quantifying avoidable productivity loss because of poor health. J Occup Environ Med. 2009;51:283-295.
14. Ostbye T, Dement JM, Krause KM. Obesity and workers' compensation. Results from the Duke Health and Safety Surveillance System. Arch Intern Med. 2007;167:766-773.
15. Goetzel RZ, Long SR, Ozminkowski RJ, Hawkins K, Wang S, Lynch W. Health, absence, disability, and presenteeism cost estimates of certain physical and mental health conditions affecting U. S. employers. J Occup Environ Med. 2004;46:398-412.
16. Special Committee on Health, Productivity, and Disability Management, American College of Occupational and Environmental Medicine. Healthy workforce/healthy economy: the role of health, productivity, and disability management in addressing the nation's health care crisis. Why an emphasis on the health of the workforce is vital to the health of the economy. J Occup Environ Med. 2009;51:114-119.
17. Goetzel RZ, Ozminkowski RJ, Baase CM, Billotti GM. Estimating the return-on-investment from changes in employee health risks on the Dow Chemical Company's health care costs. J Occup Environ Med. 2005:47: 759-768.
18. Ozminkowski RJ, Goetzel RZ, Santoro J, Saenz BJ, Eley C, Gorsky B. Estimating risk reduction required to break even in a health promotion program. Am J Health Promot. 2004;18:316-325.
19. Leutzinger JA, Ozminkowski RJ, Dunn RL, et al. Projecting future medical care costs using four scenarios of lifestyle risk rates. Am J Health Promot. 2000;15:35-44.
20. AHRQ asthma care calculator. Available at: http://statesnapshots.ahrq. gov/asthma. Accessed March 31, 2010.
21. CDC lean for life calculator. Available at: http://www.cdc.gov/leanworks/ costcalculator/index.html. Accessed July 10, 2009.
22. Hamblin A, Shearer C. Maximizing Quality and Value in Medicaid: Using Return on Investment Forecasting to Support Effective Policymaking. New York, NY: The Commonwealth Fund; 2009. Available at: http://www.commonwealthfund.org. Accessed May 4, 2009.
23. Centers for Disease Control and Prevention. Chronic Disease Prevention and Health Promotion, Chronic Disease Cost Calculator. Available at: http://www.cdc.gov/nccdphp/resources/calculator.htm. Accessed May 4, 2009.
24. Trogdon JG, Finkelstein EA, Hoerger TJ. Use of econometric models to estimate expenditure shares. Health Serv Res. 2008;43:1442-1452.
25. Trogdon JG, Finkelstein EA, Nwaise IA, Tangka FK, Orenstein D. The economic burden of chronic cardiovascular disease for major insurers. Health Promot Pract. 2007;8:234-242.
26. Lerner D, Amick IBC, Rogeres WH, Malspeis S, Bungay K, Cynn D. The Work Limitations Questionnaire. Med Care. 2001;39:72-85.